Page last updated: 2024-09-05
bradykinin, hydroxy-pro(3)- and ramiprilat
bradykinin, hydroxy-pro(3)- has been researched along with ramiprilat in 1 studies
Compound Research Comparison
Studies (bradykinin, hydroxy-pro(3)-) | Trials (bradykinin, hydroxy-pro(3)-) | Recent Studies (post-2010) (bradykinin, hydroxy-pro(3)-) | Studies (ramiprilat) | Trials (ramiprilat) | Recent Studies (post-2010) (ramiprilat) |
---|---|---|---|---|---|
9 | 0 | 0 | 173 | 9 | 10 |
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Bara, AT; Busse, R; Hecker, M; Pörsti, I | 1 |
Other Studies
1 other study(ies) available for bradykinin, hydroxy-pro(3)- and ramiprilat
Article | Year |
---|---|
Potentiation by ACE inhibitors of the dilator response to bradykinin in the coronary microcirculation: interaction at the receptor level.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Coronary Vessels; Epoprostenol; Female; In Vitro Techniques; Isoquinolines; Jugular Veins; Male; Oligopeptides; Prostaglandin Endoperoxides, Synthetic; Rabbits; Ramipril; Receptors, Bradykinin; Tetrahydroisoquinolines; Thromboxane A2; Vasoconstriction; Vasoconstrictor Agents; Vasodilation | 1994 |